Table 1 MTUHA data description
Overall | Non-survey days | Survey days | ||||
|---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Median | (IQR) | Median | IQR | Median | (IQR) | |
Day characteristics | N = 1,520 | N = 829 | N = 691 | |||
Study period | ||||||
1 – February-April 2011 | 448 | 29.5 % | 275 | 33.2 % | 173 | 25.0 % |
2 – June-July 2011 | 539 | 35.5 % | 293 | 35.3 % | 246 | 35.6 % |
3 – January-March 2012 | 533 | 35.1 % | 261 | 31.5 % | 272 | 39.4 % |
Number of days per health facility | ||||||
Median (IQR) | 85 | (77–95) | 47 | (40–53) | 39 | (36–41) |
Number of patient records per day | ||||||
Median (IQR) | 11 | (7–16) | 11 | (7–16) | 12 | (8–17) |
Patients characteristics | N = 19,579 | N = 9,834 | N = 9,745 | |||
Age (years) (N = 19,340) | ||||||
Median, IQR | 12 | (3–36) | 12 | (3–35) | 13 | (3–38) |
Gender (N = 19,530) | ||||||
Male | 8,366 | 42.8 % | 4,229 | 43.2 % | 4,137 | 42.5 % |
Female | 11,164 | 57.2 % | 5,569 | 56.8 % | 5,595 | 57.5 % |
Fevera (N = 9,785) | ||||||
Yes | 4,521 | 46.2 % | 1,803 | 41.5 % | 2,718 | 50 % |
Diagnostic and treatment | N = 19,579 | N = 9,834 | N = 9,745 | |||
RDT recorded | ||||||
Yes | 3,821 | 19.5 % | 1,811 | 18.4 % | 2,010 | 20.6 % |
RDT result (n = 3,821) | ||||||
Positive | 199 | 5.2 % | 90 | 5.0 % | 109 | 5.4 % |
Negative | 3,622 | 94.8 % | 1,721 | 95.0 % | 1,901 | 94.6 % |
AM prescription to RDT positive (n = 199) | ||||||
No AM prescription recorded | 52 | 26.1 % | 21 | 23.3 % | 31 | 28.4 % |
ALu | 85 | 42.7 % | 46 | 51.1 % | 39 | 35.8 % |
Other AM | 62 | 31.2 % | 23 | 25.6 % | 39 | 35.8 % |
AM prescribed to RDT negative (n = 3,622) | ||||||
No AM prescription recorded | 3,294 | 90.9 % | 1,553 | 90.2 % | 1,741 | 91.6 % |
ALu | 275 | 7.6 % | 148 | 8.6 % | 127 | 6.7 % |
Other AM | 53 | 1.5 % | 20 | 1.2 % | 33 | 1.7 % |
AM prescribed without RDT result (n = 15,758) | ||||||
No AM prescription recorded | 15,366 | 97.5 % | 7,813 | 97.4 % | 7,553 | 97.6 % |
ALu | 275 | 1.8 % | 160 | 2.0 % | 115 | 1.5 % |
Other AM | 117 | 0.7 % | 50 | 0.6 % | 67 | 0.9 % |